We are planning around 200 million doses (per annum) in Hyderabad, 500 million doses in other cities, says Krishna Ella, chairman of Bharat Biotech
Bharat Biotech, which has been accorded Emergency Use Authorisation from the drug regulator for its COVID-19 vaccine Covaxin, on Monday said they are setting up four vaccine manufacturing facilities with a combined capacity of 700 million doses per annum.